Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1997 | 03-1997 | 12-1996 | 09-1996 | 06-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,462 | 3,485 | 4,428 | 5,160 | 5,980 |
| Receivables | N/A | 2 | 1 | 0 | N/A |
| Other current assets | 154 | 171 | 190 | 124 | 146 |
| TOTAL | $2,616 | $3,658 | $4,619 | $5,284 | $6,126 |
| Non-Current Assets | |||||
| PPE Net | 681 | 590 | 585 | 572 | 559 |
| Other Non-Current Assets | 0 | 0 | 0 | 8 | 0 |
| TOTAL | $681 | $590 | $585 | $580 | $559 |
| Total Assets | $2,959 | $3,940 | $4,928 | $5,583 | $6,442 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 210 | 0 |
| TOTAL | $411 | $483 | $675 | $364 | $330 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 110 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $229 | $N/A |
| Total Liabilities | $411 | $483 | $675 | $593 | $330 |
| Shareholders' Equity | |||||
| Common Shares | 1,256 | 1,256 | 1,256 | 1,256 | 1,255 |
| Retained earnings | N/A | N/A | N/A | -14,032 | N/A |
| Other shareholders' equity | 1,128 | 2,040 | 2,804 | 0 | 4,596 |
| TOTAL | $2,384 | $3,296 | $4,060 | $4,990 | $5,851 |
| Total Liabilities And Equity | $2,795 | $3,779 | $4,735 | $5,583 | $6,181 |